ACHE and early-onset autosomal dominant Alzheimer disease: Examples of this class of compound include methane sulfonyl fluoride (MSF, 6, Fig. 2) – a potent inhibitor of acetylcholinesterase (AChE) – which has been evaluated in phase I and phase II clinical trials for the treatment of Alzheimer’s disease.